E
EGBOT
Guest
Tocilizumab drug offers potential treatment for patients with polymyalgia rheumatics
Source: Tocilizumab drug offers potential treatment for patients with polymyalgia rheumatics
HTML:
A drug approved to treat rheumatoid arthritis, tocilizumab (Actemra, Genentech), is a potential new therapy for patients with polymyalgia rheumatica, according to an open-label, phase II study presented at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals on November 10.
Source: Tocilizumab drug offers potential treatment for patients with polymyalgia rheumatics